Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease

Bibliography

• Iqbal K, Flory M, Khatoon S, et al. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann Neurol 2005;58(5):748-57
   Google Scholar
• Bertram L, Tanzi RE. The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 2012;107:79-100
   PubMed Web of Science ®Google Scholar
• Roses AD. On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. J Alzheimers Dis 2006;9(3 Suppl):361-6
   PubMedGoogle Scholar
• Grundke-Iqbal I, Iqbal K, Quinlan M, et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986;261(13):6084-9
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83(13):4913-17
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984;122(3):1131-5
   PubMed Web of Science ®Google Scholar
• Wong CW, Quaranta V, Glenner GG. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 1985;82(24):8729-32
   PubMed Web of Science ®Google Scholar
• Masters CL, Simms G, Weinman NA, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82(12):4245-9
   PubMed Web of Science ®Google Scholar
• Iqbal K, Grundke-Iqbal I. Opportunities and challenges in developing Alzheimer disease therapeutics. Acta Neuropathol 2011;122(5):543-9
   Google Scholar
• Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42(3 Pt 1):631-9
   PubMed Web of Science ®Google Scholar
• Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11(3):205-42
   PubMed Web of Science ®Google Scholar
• Alafuzoff I, Iqbal K, Friden H, et al. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 1987;74(3):209-25
   PubMed Web of Science ®Google Scholar
• Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6
   PubMed Web of Science ®Google Scholar
• Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256(5054):184-5
   PubMed Web of Science ®Google Scholar
• Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 1999;58(2):188-97
   PubMed Web of Science ®Google Scholar
• Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. Embo J 1990;9(13):4225-30
   PubMed Web of Science ®Google Scholar
• Iqbal K, Grundke-Iqbal I, Zaidi T, et al. Defective brain microtubule assembly in Alzheimer's disease. Lancet 1986;2(8504):421-6
   PubMed Web of Science ®Google Scholar
• Kopke E, Tung YC, Shaikh S, et al. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 1993;268(32):24374-84
   PubMed Web of Science ®Google Scholar
• Khatoon S, Grundke-Iqbal I, Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 1992;59(2):750-3
   PubMed Web of Science ®Google Scholar
• Wang JZ, Gong CX, Zaidi T, et al. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 1995;270(9):4854-60
   Google Scholar
• Wang JZ, Grundke-Iqbal I, Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res 1996;38(2):200-8
   PubMedGoogle Scholar
• Alonso AD, Zaidi T, Grundke-Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 1994;91(12):5562-6
   PubMed Web of Science ®Google Scholar
• Khatoon S, Grundke-Iqbal I, Iqbal K. Guanosine triphosphate binding to beta-subunit of tubulin in Alzheimer's disease brain: role of microtubule-associated protein tau. J Neurochem 1995;64(2):777-87
   Google Scholar
• Li B, Chohan MO, Grundke-Iqbal I, Iqbal K. Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol (Berl) 2007;113(5):501-11
   Google Scholar
• Alonso AD, Grundke-Iqbal I, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 1996;2(7):783-7
   PubMed Web of Science ®Google Scholar
• Alonso A, Zaidi T, Novak M, et al. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 2001;98(12):6923-8
   PubMed Web of Science ®Google Scholar
• Wang JZ, Grundke-Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurochem 2007;25(1):59-68
   Google Scholar
• Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 1997;94(1):298-303
   Google Scholar
• Alonso AD, Li B, Grundke-Iqbal I, Iqbal K. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proc Natl Acad Sci USA 2006;23:8864-9
   Google Scholar
• Goedert M, Jakes R, Crowther RA, et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90(11):5066-70
   PubMed Web of Science ®Google Scholar
• Matsuo ES, Shin RW, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13(4):989-1002
   Google Scholar
• Arendt T, Stieler J, Strijkstra AM, et al. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 2003;23(18):6972-81
   Google Scholar
• Planel E, Richter KE, Nolan CE, et al. Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 2007;27(12):3090-7
   PubMed Web of Science ®Google Scholar
• Run X, Liang Z, Zhang L, et al. Anesthesia induces phosphorylation of tau. J Alzheimers Dis 2009;16(3):619-26
   PubMed Web of Science ®Google Scholar
• Su B, Wang X, Drew KL, et al. Physiological regulation of tau phosphorylation during hibernation. J Neurochem 2008;105(6):2098-108
   Google Scholar
• Chohan MO, Haque N, Alonso A, et al. Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau. J Neural Transm 2005;112(8):1035-47
   PubMed Web of Science ®Google Scholar
• Li HL, Wang HH, Liu SJ, et al. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci USA 2007;104(9):3591-6
   Google Scholar
• Iqbal K, Alonso A, Chen S, et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005;1739(2-3):198-210
   PubMed Web of Science ®Google Scholar
• Kannanayakal TJ, Tao H, Vandre DD, Kuret J. Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions. Acta Neuropathol 2006;111(5):413-21
   Google Scholar
• Bonkale WL, Cowburn RF, Ohm TG, et al. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits. Brain Res 1999;818(2):383-96
   Google Scholar
• Yamaguchi H, Ishiguro K, Uchida T, et al. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol (Berl) 1996;92(3):232-41
   Google Scholar
• Pei JJ, Tanaka T, Tung YC, et al. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 1997;56(1):70-8
   Google Scholar
• Pei JJ, Braak E, Braak H, et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 1999;58(9):1010-19
   Google Scholar
• Pei JJ, Grundke-Iqbal I, Iqbal K, et al. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 1998;797(2):267-77
   Google Scholar
• Xiao J, Perry G, Troncoso J, Monteiro MJ. alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55(9):954-63
   Google Scholar
• Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 2000;485(1):87-93
   Web of Science ®Google Scholar
• Gong CX, Lidsky T, Wegiel J, et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 2000;275(8):5535-44
   Web of Science ®Google Scholar
• Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurochem 2005;22(8):1942-50
   Google Scholar
• Gong CX, Shaikh S, Wang JZ, et al. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 1995;65(2):732-8
   Google Scholar
• Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993;61(3):921-7
   PubMed Web of Science ®Google Scholar
• Li M, Lyon MK, Garcea RL. In vitro phosphorylation of the polyomavirus major capsid protein VP1 on serine 66 by casein kinase II. J Biol Chem 1995;270(43):26006-11
   Google Scholar
• Li M, Makkinje A, Damuni Z. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 1996;35(22):6998-7002
   Google Scholar
• Li M, Makkinje A, Damuni Z. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996;271(19):11059-62
   Google Scholar
• Tanimukai H, Grundke-Iqbal I, Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol 2005;166(6):1761-71
   Google Scholar
• Arnaud L, Chen S, Liu F, et al. Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I(2)(PP2A)/SET. FEBS Lett 2011;585(17):2653-9
   PubMed Web of Science ®Google Scholar
• Liu Z, Jang SW, Liu X, et al. Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol Cell 2008;29(6):665-78
   PubMed Web of Science ®Google Scholar
• Halfon S, Patel S, Vega F, et al. Autocatalytic activation of human legumain at aspartic acid residues. FEBS Lett 1998;438(1-2):114-18
   Google Scholar
• Li DN, Matthews SP, Antoniou AN, et al. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J Biol Chem 2003;278(40):38980-90
   PubMed Web of Science ®Google Scholar
• Basurto-Islas G, Grundke-Iqbal I, Tung YC, et al. Activation of asparaginyl endopeptidase leads to tau hyperphosphorylation in Alzheimer's disease. J Biol Chem 2013;288:17495-507
   PubMed Web of Science ®Google Scholar
• Bolognin S, Blanchard J, Wang X, et al. An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide. Acta Neuropathol 2012;123(1):133-51
   Google Scholar
• Wang X, Blanchard J, Kohlbrenner E, et al. The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment. FASEB J 2010;24(11):4420-32
   PubMed Web of Science ®Google Scholar
• Chen J, Martin BL, Brautigan DL. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992;257(5074):1261-4
   Google Scholar
• Lee J, Stock J. Protein phosphatase 2A catalytic subunit is methyl-esterified at its carboxyl terminus by a novel methyltransferase. J Biol Chem 1993;268(26):19192-5
   Google Scholar
• Lee J, Chen Y, Tolstykh T, Stock J. A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc Natl Acad Sci USA 1996;93(12):6043-7
   Google Scholar
• Liu R, Zhou XW, Tanila H, et al. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J Cell Mol Med 2008;12(1):241-57
   PubMed Web of Science ®Google Scholar
• Sontag E, Luangpirom A, Hladik C, et al. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 2004;63(4):287-301
   PubMed Web of Science ®Google Scholar
• Arnold CS, Johnson GV, Cole RN, et al. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 1996;271(46):28741-4
   PubMed Web of Science ®Google Scholar
• Liu F, Iqbal K, Grundke-Iqbal I, et al. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 2004;101(29):10804-9
   PubMed Web of Science ®Google Scholar
• Wang ZF, Yin J, Zhang Y, et al. Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells. J Alzheimers Dis 2010;20:145-57
   Google Scholar
• Smet-Nocca C, Broncel M, Wieruszeski JM, et al. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation. Mol Biosyst 2011;7(5):1420-9
   Google Scholar
• Yuzwa SA, Yadav AK, Skorobogatko Y, et al. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody. Amino Acids 2011;40(3):857-68
   Google Scholar
• Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 2004;1673(1-2):13-28
   Google Scholar
• Li X, Lu F, Wang JZ, Gong CX. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurochem 2006;23(8):2078-86
   Google Scholar
• Liu F, Shi J, Tanimukai H, et al. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 2009;132(Pt 7):1820-32
   PubMed Web of Science ®Google Scholar
• Gong CX, Liu F, Iqbal K. O-GlcNAc cycling modulates neurodegeneration. Proc Natl Acad Sci USA 2012;109(43):17319-20
   PubMed Web of Science ®Google Scholar
• Novak M, Kabat J, Wischik CM. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. Embo J 1993;12(1):365-70
   PubMed Web of Science ®Google Scholar
• Zilka N, Kovacech B, Barath P, et al. The self-perpetuating tau truncation circle. Biochem Soc Trans 2012;40(4):681-6
   Google Scholar
• Canu N, Dus L, Barbato C, et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 1998;18(18):7061-74
   Google Scholar
• Gamblin TC, Berry RW, Binder LI. Tau polymerization: role of the amino terminus. Biochemistry 2003;42(7):2252-7
   Google Scholar
• Rissman RA, Poon WW, Blurton-Jones M, et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 2004;114(1):121-30
   PubMed Web of Science ®Google Scholar
• Newman J, Rissman RA, Sarsoza F, et al. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Acta Neuropathol 2005;110(2):135-44
   Google Scholar
• Guillozet-Bongaarts AL, Glajch KE, Libson EG, et al. Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol 2007;113(5):513-20
   PubMed Web of Science ®Google Scholar
• Delobel P, Lavenir I, Fraser G, et al. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am J Pathol 2008;172(1):123-31
   PubMed Web of Science ®Google Scholar
• Mena R, Edwards PC, Harrington CR, et al. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol 1996;91(6):633-41
   Google Scholar
• Novak M, Jakes R, Edwards PC, et al. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci USA 1991;88(13):5837-41
   Google Scholar
• McMillan PJ, Kraemer BC, Robinson L, et al. Truncation of tau at E391 promotes early pathologic changes in transgenic mice. J Neuropathol Exp Neurol 2011;70(11):1006-19
   PubMed Web of Science ®Google Scholar
• Filipcik P, Zilka N, Bugos O, et al. First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol Aging 2012;33(7):1448-56
   Google Scholar
• Min SW, Cho SH, Zhou Y, et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 2010;67(6):953-66
   PubMed Web of Science ®Google Scholar
• Cohen TJ, Guo JL, Hurtado DE, et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2011;2:252
   PubMed Web of Science ®Google Scholar
• Cook C, Carlomagno Y, Gendron TF, et al. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet 2013. [Epub ahead of print]
   Google Scholar
• Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393(6686):702-5
   PubMed Web of Science ®Google Scholar
• Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43(6):815-25
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95(13):7737-41
   PubMed Web of Science ®Google Scholar
• Stanford PM, Shepherd CE, Halliday GM, et al. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 2003;126(Pt 4):814-26
   Google Scholar
• Bronner IF, ter Meulen BC, Azmani A, et al. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 2005;128(Pt 11):2645-53
   Google Scholar
• de Silva R, Lashley T, Strand C, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol 2006;111(4):329-40
   Google Scholar
• Sengupta A, Grundke-Iqbal I, Iqbal K. Regulation of phosphorylation of tau by protein kinases in rat brain. Neurochem Res 2006;31(12):1473-80
   Google Scholar
• Alonso AD, Mederlyova A, Novak M, et al. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 2004;279(33):34873-81
   Google Scholar
• Liang Z, Liu F, Grundke-Iqbal I, et al. Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem 2007;103(6):2462-70
   Google Scholar
• Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005;309(5733):476-81
   PubMed Web of Science ®Google Scholar
• Basurto-Islas G, Luna-Munoz J, Guillozet-Bongaarts AL, et al. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol 2008;67(5):470-83
   PubMed Web of Science ®Google Scholar
• Zilka N, Filipcik P, Koson P, et al. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006;580(15):3582-8
   PubMed Web of Science ®Google Scholar
• Yuzwa SA, Macauley MS, Heinonen JE, et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 2008;4(8):483-90
   PubMed Web of Science ®Google Scholar
• Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer's disease. J Neurochem 2000;75(1):436-9
   PubMed Web of Science ®Google Scholar
• Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005;64(2):113-22
   PubMed Web of Science ®Google Scholar
• Wolfe DM, Lee JH, Kumar A, et al. Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur J Neurochem 2013;37(12):1949-61
   Google Scholar
• Hegde AN, Upadhya SC. Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. Biochim Biophys Acta 2011;1809(2):128-40
   Google Scholar
• Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 2007;27(34):9115-29
   PubMed Web of Science ®Google Scholar
• Theunis C, Crespo-Biel N, Gafner V, et al. Efficacy and safety of a liposome-based vaccine against protein tau, assessed in tau.P301L mice that model tauopathy. PLoS One 2013;8(8):e72301
   PubMed Web of Science ®Google Scholar
• d'Abramo C, Acker CM, Jimenez HT, Davies P. Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One 2013;8(4):e62402
   Google Scholar
• Rosenmann H. Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies. Curr Alzheimer Res 2013;10(3):217-28
   Google Scholar
• Elliott E, Atlas R, Lange A, Ginzburg I. Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism. Eur J Neurochem 2005;22(5):1081-9
   Google Scholar
• Iqbal K, Grundke-Iqbal I, Smith AJ, et al. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 1989;86(14):5646-50
   Google Scholar
• Gilman S, Koller M, Black RS, et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005;64(9):1553-62
   PubMed Web of Science ®Google Scholar
• Blanchard J, Wanka L, Tung YC, et al. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Abeta and tau pathologies in 3xTg-AD mice. Acta Neuropathol 2010;120(5):605-21
   Google Scholar